SLNO – Soleno Therapeutics Inc
Float Short %
21.18
Margin Of Safety %
Put/Call OI Ratio
0.36
EPS Next Q Diff
0.28
EPS Last/This Y
4.57
EPS This/Next Y
4.02
Price
39.4
Target Price
111.92
Analyst Recom
1.08
Performance Q
-18.91
Upside
-263.6%
Beta
-3.16
Ticker: SLNO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | SLNO | 42.36 | 0.32 | 0.07 | 30091 |
| 2026-01-26 | SLNO | 42.86 | 0.31 | 0.04 | 30747 |
| 2026-01-27 | SLNO | 43.21 | 0.31 | 0.20 | 31075 |
| 2026-01-28 | SLNO | 41.6 | 0.32 | 2.63 | 30923 |
| 2026-01-29 | SLNO | 40.52 | 0.33 | 0.54 | 31098 |
| 2026-01-30 | SLNO | 38.59 | 0.33 | 0.04 | 29932 |
| 2026-02-02 | SLNO | 42.31 | 0.36 | 0.44 | 28926 |
| 2026-02-03 | SLNO | 44.02 | 0.38 | 0.01 | 29888 |
| 2026-02-04 | SLNO | 42.15 | 0.36 | 1.22 | 30832 |
| 2026-02-05 | SLNO | 39.55 | 0.37 | 0.06 | 31286 |
| 2026-02-06 | SLNO | 41.6 | 0.37 | 1.18 | 31662 |
| 2026-02-09 | SLNO | 40.87 | 0.37 | 0.33 | 31863 |
| 2026-02-10 | SLNO | 40.48 | 0.37 | 0.20 | 31902 |
| 2026-02-11 | SLNO | 40.02 | 0.38 | 308.54 | 32147 |
| 2026-02-12 | SLNO | 38.67 | 0.40 | 0.05 | 32643 |
| 2026-02-13 | SLNO | 37.23 | 0.39 | 0.04 | 33037 |
| 2026-02-17 | SLNO | 38.5 | 0.39 | 0.06 | 33248 |
| 2026-02-18 | SLNO | 38.62 | 0.37 | 3.25 | 33248 |
| 2026-02-20 | SLNO | 39.37 | 0.36 | 0.52 | 33008 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | SLNO | 42.37 | - | - | 0.19 |
| 2026-01-26 | SLNO | 42.84 | - | - | 0.19 |
| 2026-01-27 | SLNO | 43.18 | - | - | 0.19 |
| 2026-01-28 | SLNO | 41.60 | - | - | 0.19 |
| 2026-01-29 | SLNO | 40.55 | - | - | 0.19 |
| 2026-01-30 | SLNO | 38.61 | - | - | 0.19 |
| 2026-02-02 | SLNO | 42.31 | - | - | 0.19 |
| 2026-02-03 | SLNO | 44.04 | - | - | 0.19 |
| 2026-02-04 | SLNO | 42.13 | - | - | 0.19 |
| 2026-02-05 | SLNO | 39.58 | - | - | 0.19 |
| 2026-02-06 | SLNO | 41.57 | - | - | 0.19 |
| 2026-02-09 | SLNO | 40.87 | - | - | 0.19 |
| 2026-02-10 | SLNO | 40.49 | - | - | 0.19 |
| 2026-02-11 | SLNO | 39.99 | - | - | 0.19 |
| 2026-02-12 | SLNO | 38.69 | - | - | 0.19 |
| 2026-02-13 | SLNO | 37.24 | - | - | 0.19 |
| 2026-02-17 | SLNO | 38.52 | - | - | 0.19 |
| 2026-02-18 | SLNO | 38.61 | - | - | 0.19 |
| 2026-02-19 | SLNO | 39.43 | - | - | 0.19 |
| 2026-02-20 | SLNO | 39.40 | - | - | 0.19 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | SLNO | 0.00 | 20.31 | 22.09 |
| 2026-01-26 | SLNO | 0.00 | 19.93 | 22.09 |
| 2026-01-27 | SLNO | 0.00 | 19.93 | 22.09 |
| 2026-01-28 | SLNO | 0.00 | 19.93 | 23.19 |
| 2026-01-29 | SLNO | 0.00 | 19.93 | 23.19 |
| 2026-01-30 | SLNO | 0.00 | 19.93 | 23.19 |
| 2026-02-02 | SLNO | 0.00 | 21.20 | 23.28 |
| 2026-02-03 | SLNO | 0.00 | 21.20 | 23.28 |
| 2026-02-04 | SLNO | 0.00 | 21.20 | 23.28 |
| 2026-02-05 | SLNO | 0.00 | 21.20 | 23.28 |
| 2026-02-06 | SLNO | 0.00 | 21.20 | 23.28 |
| 2026-02-10 | SLNO | 0.00 | 18.96 | 23.28 |
| 2026-02-11 | SLNO | 0.00 | 18.96 | 21.18 |
| 2026-02-12 | SLNO | 0.00 | 18.96 | 21.18 |
| 2026-02-13 | SLNO | 0.00 | 18.96 | 21.18 |
| 2026-02-17 | SLNO | 0.00 | 20.14 | 21.18 |
| 2026-02-18 | SLNO | 0.00 | 20.14 | 21.18 |
| 2026-02-19 | SLNO | 0.00 | 20.14 | 21.18 |
| 2026-02-20 | SLNO | 0.00 | 20.14 | 21.18 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.47
Avg. EPS Est. Current Quarter
0.62
Avg. EPS Est. Next Quarter
0.75
Insider Transactions
Institutional Transactions
20.14
Beta
-3.16
Average Sales Estimate Current Quarter
82
Average Sales Estimate Next Quarter
96
Fair Value
Quality Score
32
Growth Score
22
Sentiment Score
80
Actual DrawDown %
56.4
Max Drawdown 5-Year %
-98
Target Price
111.92
P/E
Forward P/E
9.35
PEG
P/S
21.43
P/B
4.27
P/Free Cash Flow
EPS
-1.84
Average EPS Est. Cur. Y
0.19
EPS Next Y. (Est.)
4.21
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-79.5
Relative Volume
0.95
Return on Equity vs Sector %
-44.9
Return on Equity vs Industry %
-27.4
EPS 1 7Days Diff
EPS 1 30Days Diff
0.04
EBIT Estimation
Soleno Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 152
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
stock quote shares SLNO – Soleno Therapeutics Inc Stock Price stock today
news today SLNO – Soleno Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch SLNO – Soleno Therapeutics Inc yahoo finance google finance
stock history SLNO – Soleno Therapeutics Inc invest stock market
stock prices SLNO premarket after hours
ticker SLNO fair value insiders trading